FindOwnerSearch
Brands and Their Owners
| KELONIA THERAPEUTICS, INC. contact information is shown below | |
| Owner: | KELONIA THERAPEUTICS, INC. |
|---|---|
| Owner Address: | 5 Channel Center, Suite 501 Boston MA 02210 |
| Owner Web Site | |
| Owner Phone | |
| Owner Toll Free | |
| Owner Fax |
| Brand: |
IGPS |
|---|---|
| Description: | Pharmaceutical, medical and clinical preparations for use in cell and gene therapy; pharmaceutical, medical and clinical preparations for use in cell and gene therapy for treatment of cancer and genetic diseases; Cell and gene therapy vectors for treatment of cancer and genetic diseases; therapeutic preparations for enhancing the targeting, delivery, and effectiveness of cancer treatments; t-cells for medical and therapeutic use; cell-based immunotherapeutic treatment by way of genetically modified cells for use in human therapeutics and the treatment of cancer and genetic diseases; pharmaceutical and biological preparations based on gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy for use in human therapeutics, namely, therapeutic pharmaceuticals developed through genome modifications for the treatment of cancer and genetic diseases;Scientific and medical research services in the field of cell and gene therapies; Scientific and medical research services in the field of cell and gene therapies using engineered viral vectors; |
| Category: | PHARMACEUTICAL |
| Brand: |
IVGPS |
|---|---|
| Description: | Pharmaceutical, medical and clinical preparations for use in cell and gene therapy; pharmaceutical, medical and clinical preparations for use in cell and gene therapy for treatment of cancer and genetic diseases; Cell and gene therapy vectors for treatment of cancer and genetic diseases; therapeutic preparations for enhancing the targeting, delivery, and effectiveness of cancer treatments; t-cells for medical and therapeutic use; cell-based immunotherapeutic treatment by way of genetically modified cells for use in human therapeutics and the treatment of cancer and genetic diseases; pharmaceutical and biological preparations based on gene, genome and cellular editing, modulation, modification, engineering, regulation, repair and therapy for use in human therapeutics, namely, therapeutic pharmaceuticals developed through genome modifications for the treatment of cancer and genetic diseases;Scientific and medical research services in the field of cell and gene therapies; Scientific and medical research services in the field of cell and gene therapies using engineered viral vectors; |
| Category: | PHARMACEUTICAL |
| Brand: |
KELONIA |
|---|---|
| Description: | Pharmaceutical and medical preparations for use in cell and gene therapy for treatment of cancer and genetic diseases; Gene therapy and viral vectors for treatment of cancer and genetic diseases;Clinical viral vector preparations for use in cell and gene therapy;Medical services in the field of cell and gene therapies; medical services in the field of cell and gene therapies using engineered viral vectors;Scientific and medical research services in the field of cell and gene therapies; Scientific and medical research services in the field of cell and gene therapies using engineered viral vectors; |
| Category: | PHARMACEUTICAL MEDICAL PREPARATIONS |
| Brand: |
KELONIA |
|---|---|
| Description: | The mark consists of the word Kelonia followed by a stylized four-point star.;Pharmaceutical and medical preparations for use in cell and gene therapy for treatment of cancer and genetic diseases; Gene therapy and viral vectors for treatment of cancer and genetic diseases;Color is not claimed as a feature of the mark.;Clinical viral vector preparations for use in cell and gene therapy;Medical services in the field of cell and gene therapies; medical services in the field of cell and gene therapies using engineered viral vectors;Scientific and medical research services in the field of cell and gene therapies; Scientific and medical research services in the field of cell and gene therapies using engineered viral vectors; |
| Category: |